Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726
SUZHOU, China, Dec. 30, 2024 /PRNewswire/ -- Hangzhou Sino-US Huadong Medicine Co., Ltd. (hereinafter referred to as "Huadong Medicine"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), and SynerK PharmaTech (Suzhou) Co., Ltd. (hereinafter referred to as "SynerK") have reached a strategic cooperation. The two parties will jointly develop the small nucleic acid (siRNA) drug SNK-2726, targeting angiotensinogen...
Maypharm Unveils Revolutionary Hybrid Filler, Hyalmass Aqua-Exosome: The Future of Skin Hydration and Regeneration
Introducing Hyaluronic Acid, Exosomes, and PDRN SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ -- Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a groundbreaking hybrid mesotherapy filler designed to redefine skin hydration and revitalization. Hyalmass Aqua-Exosome Maypharm Co., Ltd. is set to revolutionize the...
Taiwanese Companies Lead Innovation in AI-Powered Smart Wearables
TAIPEI, Dec. 30, 2024 /PRNewswire/ -- In the rapidly evolving tech landscape, smart wearable devices enriched with artificial intelligence (AI) and augmented reality (AR) are redefining the boundaries of innovation. Leading the charge, members of the AI on Chip Industrial Cooperation Strategic Alliance, including Jorjin, Singular Wings Medical, and SoundLand, are demonstrating formidable expertise by leveraging their distinctive technological capabilities. ...
“Closing the Women’s Health Gap – Highlights of Biotropics Malaysia clinical study by Women, on Women, for Women”
SHAH ALAM, Malaysia, Dec. 30, 2024 /PRNewswire/ -- While gender parity has seen progress in recent years, the women's health gap remains significant. Women, despite comprising half of the global labor force, often face under-diagnosis and under-representation in healthcare research. Biotropics Malaysia is addressing this disparity by advancing clinical studies led by women, focused on health areas that have been...
Talent Satisfaction Elevated! YANNIGO Wins “Best Employee Retention Award” for its Dedication to Employee Well-being and a Happy Workplace
TAICHUNG, Dec. 30, 2024 /PRNewswire/ -- In today's competitive workplace, an organization's ability to retain talent has become a critical measure of its success and sustainable development. YANNIGO, a nutrition and wellness company headquartered in Taichung, was recently awarded the "2024 Best Employee Retention Award" by 104 Job Bank, recognizing it as a role model for employee happiness among small...
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
MELBOURNE, Australia and INDIANAPOLIS, Dec. 30, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX; Nasdaq: TLX, Telix, the Company) today announces that it has submitted its Biologics License Application (BLA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX250-CDx (Zircaix®, 89Zr- girentuximab) kidney cancer imaging. TLX250-CDx is an investigational...
BMG Completed Acquisition of High-Quality Assets, Marking a New Chapter in Diversified Growth
CHENGDU, China, Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Nasdaq: BGM) (the "Company" or "BGM"), a leading global pharmaceutical enterprise, today announced completion of the acquisition of the intelligent platform of AIX Inc. It marks BGM's official entry into the domains of AI intelligent technology and financial/insurance services, opening up new opportunities for the integrated development of healthcare, pharmaceuticals,...
In-Depth Analysis of BGM Group: Innovating Pharmaceuticals and Insurance through AI
CHONGQING, China, Dec. 27, 2024 /PRNewswire/ -- BGM Group Ltd. (Stock Code: BGM) has successfully acquired Rongshu Technology and Xinbao Investment Company, both subsidiaries of AIX Corp. (Stock Code: AIFU), in a transaction valued at approximately $140 million. This acquisition presents substantial opportunities for BGM Group's AI-driven insurance business. 1. Building an Efficient Equity Structure to Enhance Synergies With...
Fangzhou Inc. Honored as an “Outstanding Innovation Firm” by Yangcheng Evening News
GUANGZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, was honored as an "Outstanding Innovation Firm" at the "Precision Engineering: 2024 Technology Pioneers Gala" held by Yangcheng Evening News on December 13th. Fangzhou garnered recognition for its significant milestones in 2024, including a successful...
Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference
ROCKVILLE, Md. and SUZHOU, China, Dec. 27, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that its Chairman and CEO, Dr. Dajun Yang, has accepted an invitation to present on the company's...
